Alto Neuroscience, Inc. (ANRO)
NYSE: ANRO · Real-Time Price · USD
3.890
+0.170 (4.57%)
Dec 20, 2024, 4:00 PM EST - Market closed
Alto Neuroscience Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2023 | FY 2022 | FY 2021 |
| Dec '24 Dec 20, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| Market Capitalization | 105 | - | - | - |
| Enterprise Value | -61 | - | - | - |
| Debt / Equity Ratio | 0.09 | 0.14 | 0.28 | - |
| Quick Ratio | 12.96 | 14.72 | 8.75 | 15.16 |
| Current Ratio | 13.09 | 15.22 | 8.85 | 15.30 |
| Return on Equity (ROE) | -56.72% | -67.95% | -88.40% | - |
| Return on Assets (ROA) | -32.36% | -34.38% | -45.81% | - |
| Return on Capital (ROIC) | -34.75% | -37.30% | -50.29% | - |
| Buyback Yield / Dilution | -408.92% | -8.27% | -42.78% | - |
| Total Shareholder Return | -408.92% | -8.27% | -42.78% | - |
Source: S&P Capital IQ. Standard template.
Financial Sources.